Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea
· Delayed Price · Currency is KRW 6,850.00
+60.00 (0.88%)
At close: Dec 5, 2025
Seoulin Bioscience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 76,738 | 75,410 | 89,569 | 104,708 | 80,539 | 65,085 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | - | - | Upgrade
|
| Revenue | 76,738 | 75,410 | 89,569 | 104,708 | 80,539 | 65,085 | Upgrade
|
| Revenue Growth (YoY) | -6.52% | -15.81% | -14.46% | 30.01% | 23.74% | 19.62% | Upgrade
|
| Cost of Revenue | 58,854 | 56,450 | 69,699 | 80,417 | 59,469 | 48,569 | Upgrade
|
| Gross Profit | 17,884 | 18,961 | 19,871 | 24,292 | 21,070 | 16,516 | Upgrade
|
| Selling, General & Admin | 14,387 | 14,697 | 15,016 | 12,475 | 11,144 | 9,626 | Upgrade
|
| Research & Development | 1,247 | 1,214 | 785.23 | 870.46 | 786.82 | 998.37 | Upgrade
|
| Amortization of Goodwill & Intangibles | 81.81 | 92.26 | 112.83 | 163.33 | 459.01 | 371.5 | Upgrade
|
| Other Operating Expenses | 496.65 | 483.24 | 441.22 | 396.47 | 382.27 | 335.09 | Upgrade
|
| Operating Expenses | 17,531 | 18,008 | 17,376 | 15,094 | 13,619 | 12,046 | Upgrade
|
| Operating Income | 353.32 | 952.67 | 2,495 | 9,198 | 7,451 | 4,471 | Upgrade
|
| Interest Expense | -379.31 | -329.7 | -2,482 | -2,287 | -224.55 | -18.66 | Upgrade
|
| Interest & Investment Income | 688.76 | 996.22 | 2,051 | 1,637 | 303.78 | 253.7 | Upgrade
|
| Earnings From Equity Investments | 10.67 | 88.53 | 85.1 | 121.01 | 114.5 | 89.12 | Upgrade
|
| Currency Exchange Gain (Loss) | -50.36 | 10.01 | -308.95 | -63.7 | -178.86 | 144.62 | Upgrade
|
| Other Non Operating Income (Expenses) | 397.41 | 666.37 | 3,441 | 3,808 | -397.15 | 724.33 | Upgrade
|
| EBT Excluding Unusual Items | 1,020 | 2,384 | 5,280 | 12,413 | 7,069 | 5,664 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,968 | 1,986 | -4,966 | 2,011 | 160.11 | 118.2 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.32 | -13.69 | -31.42 | -1.06 | 14,153 | 0.27 | Upgrade
|
| Asset Writedown | -152.6 | -152.6 | - | -393.03 | -1,044 | - | Upgrade
|
| Other Unusual Items | -125.86 | -648.11 | -2,211 | - | - | - | Upgrade
|
| Pretax Income | 2,710 | 3,556 | -1,929 | 14,029 | 20,338 | 5,782 | Upgrade
|
| Income Tax Expense | 43.05 | 415.34 | 394.29 | 3,464 | 4,459 | 981.4 | Upgrade
|
| Earnings From Continuing Operations | 2,667 | 3,140 | -2,323 | 10,565 | 15,879 | 4,801 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 29.47 | -111.04 | - | Upgrade
|
| Net Income to Company | 2,667 | 3,140 | -2,323 | 10,595 | 15,768 | 4,801 | Upgrade
|
| Minority Interest in Earnings | -546.34 | -226.34 | 2,206 | -435.72 | -178.88 | 91.64 | Upgrade
|
| Net Income | 2,121 | 2,914 | -117.55 | 10,159 | 15,589 | 4,893 | Upgrade
|
| Net Income to Common | 2,121 | 2,914 | -117.55 | 10,159 | 15,589 | 4,893 | Upgrade
|
| Net Income Growth | - | - | - | -34.84% | 218.64% | -44.93% | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 9 | 11 | 9 | 9 | Upgrade
|
| Shares Change (YoY) | 7.12% | -0.50% | -19.46% | 23.72% | -0.07% | -1.26% | Upgrade
|
| EPS (Basic) | 245.75 | 334.30 | -13.42 | 1158.09 | 1773.24 | 556.14 | Upgrade
|
| EPS (Diluted) | 226.02 | 334.08 | -13.42 | 798.15 | 1773.07 | 555.99 | Upgrade
|
| EPS Growth | - | - | - | -54.98% | 218.90% | -44.22% | Upgrade
|
| Free Cash Flow | 588.48 | -4,660 | -14.95 | -4,817 | 7,984 | 3,283 | Upgrade
|
| Free Cash Flow Per Share | 62.78 | -534.60 | -1.71 | -442.90 | 908.19 | 373.19 | Upgrade
|
| Dividend Per Share | 97.684 | 97.684 | - | - | - | - | Upgrade
|
| Gross Margin | 23.31% | 25.14% | 22.18% | 23.20% | 26.16% | 25.38% | Upgrade
|
| Operating Margin | 0.46% | 1.26% | 2.79% | 8.78% | 9.25% | 6.87% | Upgrade
|
| Profit Margin | 2.76% | 3.86% | -0.13% | 9.70% | 19.36% | 7.52% | Upgrade
|
| Free Cash Flow Margin | 0.77% | -6.18% | -0.02% | -4.60% | 9.91% | 5.04% | Upgrade
|
| EBITDA | 1,573 | 2,318 | 3,781 | 10,215 | 9,381 | 6,455 | Upgrade
|
| EBITDA Margin | 2.05% | 3.07% | 4.22% | 9.75% | 11.65% | 9.92% | Upgrade
|
| D&A For EBITDA | 1,219 | 1,365 | 1,287 | 1,017 | 1,930 | 1,984 | Upgrade
|
| EBIT | 353.32 | 952.67 | 2,495 | 9,198 | 7,451 | 4,471 | Upgrade
|
| EBIT Margin | 0.46% | 1.26% | 2.79% | 8.78% | 9.25% | 6.87% | Upgrade
|
| Effective Tax Rate | 1.59% | 11.68% | - | 24.69% | 21.92% | 16.97% | Upgrade
|
| Advertising Expenses | - | 357.36 | 227.45 | 119.05 | 141.61 | 183.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.